版本:
中国

BRIEF-AmpliPhi Biosciences announces positive feedback from FDA on phase 2 development proposal

April 17 AmpliPhi Biosciences Corp

* AmpliPhi Biosciences announces positive feedback from FDA on phase 2 development proposal

* AmpliPhi Biosciences Corp - begins formal review of strategic options

* AmpliPhi Biosciences - FDA provided positive feedback on development proposal to commence phase 2 trial with proprietary Bacteriophage cocktail ab-sa01

* AmpliPhi biosciences - company has retained H.C. Wainwright & Co., LLC to advise co and its board of directors in review of strategic alternatives Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐